Piper Sandler on Oruka Therapeutics (ORKA): 'We remain bullish into a catalyst-rich year+'

Go back to Piper Sandler on Oruka Therapeutics (ORKA): 'We remain bullish into a catalyst-rich year+'
(NASDAQ: ORKA) Delayed: 111.04 +2.92 (2.70%)
Previous Close $108.12    52 Week High
Open $106.02    52 Week Low
Day High $111.37    P/E N/A 
Day Low $105.10    EPS
Volume 1,047,422